FBT (First Trust NYSE Arca Biotechnology Index Fund) Stock Analysis - Analyst Ratings

First Trust NYSE Arca Biotechnology Index Fund (FBT) is a publicly traded the market company. As of May 21, 2026, FBT trades at $204.57 with a market cap of $0 and a P/E ratio of 0.00. FBT moved +2.10% today. Year to date, FBT is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces FBT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate FBT?

The average price target is $0.00.

FBT Key Metrics

Key financial metrics for FBT
MetricValue
Price$204.57
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume112.87K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

FBT Analyst Consensus

FBT analyst coverage data. Average price target: $0.00.

Latest FBT News

Common questions about FBT

What do analysts rate FBT?
The average price target is $0.00.
Does Rallies show FBT price targets?
Yes. Rallies tracks FBT analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is FBT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for FBT. It does not provide personalized investment advice.
FBT

FBT